![Shu Wen Li](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Shu Wen Li
Director/Board Member at Impax Laboratories (Taiwan), Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Jeffrey D. Nornhold | M | 58 |
Impax Laboratories (Taiwan), Inc.
![]() Impax Laboratories (Taiwan), Inc. Pharmaceuticals: MajorHealth Technology Impax Laboratories (Taiwan), Inc. engages in the research, development and manufacturing of oral controlled-release dosage forms of generic drugs. It also involves in the formulation and clinical development of alternate dosage forms of drugs for diseases in the central nervous system. Its products include branded pharmaceutical product such as IPX066 and generic pharmaceutical products such as Acarbose, Dantrolene Sodium, and Fenofibrate tablets. The company was founded on May 4, 2007 and is headquartered in Miaoli, Taiwan. | - |
Bryan Reasons | M | 56 |
Impax Laboratories (Taiwan), Inc.
![]() Impax Laboratories (Taiwan), Inc. Pharmaceuticals: MajorHealth Technology Impax Laboratories (Taiwan), Inc. engages in the research, development and manufacturing of oral controlled-release dosage forms of generic drugs. It also involves in the formulation and clinical development of alternate dosage forms of drugs for diseases in the central nervous system. Its products include branded pharmaceutical product such as IPX066 and generic pharmaceutical products such as Acarbose, Dantrolene Sodium, and Fenofibrate tablets. The company was founded on May 4, 2007 and is headquartered in Miaoli, Taiwan. | - |
Chen Tang Chang | M | - |
Impax Laboratories (Taiwan), Inc.
![]() Impax Laboratories (Taiwan), Inc. Pharmaceuticals: MajorHealth Technology Impax Laboratories (Taiwan), Inc. engages in the research, development and manufacturing of oral controlled-release dosage forms of generic drugs. It also involves in the formulation and clinical development of alternate dosage forms of drugs for diseases in the central nervous system. Its products include branded pharmaceutical product such as IPX066 and generic pharmaceutical products such as Acarbose, Dantrolene Sodium, and Fenofibrate tablets. The company was founded on May 4, 2007 and is headquartered in Miaoli, Taiwan. | - |
Connections Chart
Multi-company connection
Statistics
Country | Connections | % of total |
---|---|---|
Taiwan | 3 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Shu Wen Li
- Personal Network